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Ethical dilemmas in scientific
publication: pitfalls and
solutions for editors
Dilemas éticos na publicação
científica: dificuldades e soluções
para editores
ABSTRACT
Editors of scientific journals need to be conversant with the mechanisms by which
scientific misconduct is amplified by publication practices. This paper provides
definitions, ways to document the extent of the problem, and examples of editorial
attempts to counter fraud. Fabrication, falsification, duplication, ghost authorship,
gift authorship, lack of ethics approval, non-disclosure, ‘salami’ publication, conflicts
of interest, auto-citation, duplicate submission, duplicate publications, and plagiarism
are common problems. Editorial misconduct includes failure to observe due process,
undue delay in reaching decisions and communicating these to authors, inappropriate
review procedures, and confounding a journal’s content with its advertising or
promotional potential. Editors also can be admonished by their peers for failure to
investigate suspected misconduct, failure to retract when indicated, and failure to
abide voluntarily by the six main sources of relevant international guidelines on
research, its reporting and editorial practice. Editors are in a good position to promulgate
reasonable standards of practice, and can start by using consensus guidelines on
publication ethics to state explicitly how their journals function. Reviewers, editors,
authors and readers all then have a better chance to understand, and abide by, the rules
of publishing.
KEYWORDS: Publications, ethics. Authorship. Publication bias. Editorial
policies.
RESUMO
Editores de revistas científicas precisam estar atentos aos mecanismos de disseminação
de condutas inadequadas no processo de publicação. Este artigo fornece definições,
formas de documentar a extensão do problema e exemplos de iniciativas para conter
fraudes editorias. Fabricação, falsificação, duplicação, autoria-fantasma, autoria
concedida, falta de ética na aprovação de manuscritos, não-divulgação desses fatos,
publicação “salami”, conflitos de interesse, autocitação, submissão e publicação
duplicadas, e plágio são problemas comuns. A conduta editorial inadequada inclui:
falha em seguir o processo devido, atraso nas decisões e comunicação com os autores,
falhas na revisão, e confundir o conteúdo de um periódico com seu potencial
promocional e de propaganda. Os editores podem ser advertidos por seus pares por
não investigar comportamento científico suspeito, por não se retratar quando indicado
ou não obedecer as seis principais fontes internacionais de orientação em pesquisa,
publicação e política editorial. Os editores estão em posição privilegiada para promover
práticas adequadas, adotando orientações éticas e claras sobre os procedimentos
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adotados nos periódicos. Assim, revisores, editores, autores e leitores terão condições
de compreender e seguir as normas de publicação.
DESCRITORES: Publicações, ética. Autoria. Viés de publicação. Políticas
editoriais.
INTRODUCTION
Editors who write about publication ethics without
considering the research culture are as far downstream
as doctors, in the emergency room, are from seatbelt
legislation. As editors, we need to be interested in,
and conversant with the reasons for scientific mis-
conduct; and how fraudulent acts are perpetuated and
encouraged by publication practices. The objective
of this paper was to present definitions, means by
which the extent of the problem can be documented,
and examples of current attempts to counter fraud.
The year 2005 was a good one for fraud, and most of
the top journals had something to contribute. Sci-
ence retracted work on stem cells amidst international
publicity,6 Cell took back some research on trypano-
somiasis,9 British Medical Journal (BMJ) finally
published the whole story of the researcher and the
termites that ate his data.10 Findings on the Indo-
Mediterranean diet, long suspected as too good to be
true, were exposed as an elaborate hoax, by the Lan-
cet,2 who were also obliged to publish an expression
of concern,3 prior to retracting4 the entirety of a fabri-
cated cohort study on oral cancer. The editors of the
Canadian Medical Journal resigned following a dis-
pute with their publisher over editorial freedom.5 It
was a busy year, even for the Bulletin of the World
Health Organization, a much smaller journal. The
Bulletin publishes mostly policy papers – and there-
fore lacks the irreproducibility check common to most
basic science, but even so, there have been the usual
amount of authorship disputes, and attempts at du-
plicate submission. We have also been obliged to
refer cases on contractual loopholes that resulted in
research being done without ethical committee ap-
proval, and investigate the rather grey area of ethical
approval for non-governmental organizations doing
operational research. However, it was also a good year
in terms of making progress on long-standing defi-
cits – an international clinical trials registry was es-
tablished at World Health Organization (WHO),15 and
the United Kingdom finally appointed a panel on
research integrity.13
In these adversarial times, what can editors do to build
and maintain the reputations of their journals? We
review definitions of the most common types of mis-
conduct, and provide pointers to resources for edi-
tors’ intent on doing their best to run a clean ship. As
far as authors are concerned, there are both sins of
omission and commission: fabrication, falsification,
duplication, ghost authorship, gift authorship, lack
of ethics approval, non-disclosure, ‘salami’ publica-
tion, conflicts of interest, auto-citation, duplicate
submission, duplicate publications, and plagiarism.
There are important incentives to ethical misconduct
on the part of all involved and editors too should be
held to standards of reasonable practice. However,
given the lack of oversight, and the traditional impu-
nity with which editors made decisions, definitions
of editorial misconduct are less clear – submission of
research to one’s own journal for example, ranges from
a proscribed activity, to a common occurrence, to the
only rationale for the title. Examples of editorial mis-
conduct include failure to observe due process, un-
due delay in reaching decisions and communicating
these to authors, inappropriate review procedures, and
confounding a journal’s content with its advertising
or promotional potential. Editors also can be admon-
ished by their peers for failure to investigate suspected
misconduct, failure to retract when indicated, and fail-
ure to abide voluntarily by the six main sources of
relevant international guidelines on conducting, re-
porting, and editing research:
• Council of International Organizations for Medical
Sciences (CIOMS)16
• World Medical Association (WMA)*
• Consolidated Standards of Reporting Trials
(CONSORT)7
• International Committee of Medical Journal
Editors (ICJME)**
• World Association of Medical Editors (WAME)***
• Committee on Publication Ethics (COPE)****
*World Medical Association - WMA. The World Medical Association Declaration of Helsinki: Ethical Principles for Medical Research
Involving Human Subjects. Available from http://www.wma.net/e/policy/b3.htm [2006 Jul 7]
**International Committee of Medical Journal Editors. Uniform requirements for manuscripts submitted to biomedical journals: writing and
editing for biomedical publication. Available from http://www.icmje.org [2006 Jul 7]
***World Association of Medical Editors - WAME. Recommendations on Publication Ethics Policies for Medical Journals. Available from
http://www.wame.org/pubethicrecom.htm. [2006 Jul 7]
****Committee on Publication Ethics - COPE. Guidelines on good publication and the Code of Conduct. Available from http://
www.publicationethics.org.uk/guidelines [2006 Jul 7]
26 Rev Saúde Pública 2006;40(N Esp):24-9Ethics in scientific publication
Gollogly L & Momen H
COMMON PITFALLS: WHO WROTE THIS
PAPER, AND HOW MANY TIMES HAS IT BEEN
PUBLISHED?
COPE has classified the most common types of ethi-
cal problems in scientific publications. The two most
frequent were disputes on authorship and duplicate
publication.
Authorship
The ICMJE,* also known as the Vancouver group (be-
cause of the location of their first meeting) have given
three conditions on which authorship credit should
be based. These criteria are: 1) substantial contribu-
tions to conception and design, or acquisition of data,
or analysis and interpretation of data; 2) drafting the
article or revising it critically for important intellec-
tual content; and 3) final approval of the version to
be published. All three conditions should be met for
assigning authorship.
Although the ICMJE criteria are clear, many authors are
unaware of them or prefer to use their own ad-hoc crite-
ria for deciding authorship. Editors are therefore often
faced with deciding on rightful authorship. Ethical prob-
lems regarding authorship of scientific manuscripts can
be divided into two main categories: Inclusion of au-
thors who did not contribute substantially to the study
(gift authorship) and exclusion of authors who did con-
tribute significantly to the study (ghost authorship).
Gift authorship usually involves inclusion of people
hierarchically senior to the author(s) such as their
supervisor, team leader, head of department or direc-
tor of institute. Their names may be included as a
recognition of their contribution to the research topic,
the provision of funding for the research, granting of
laboratory space to carry it out or general advice.
Although these contributions can be acknowledged
they do not by themselves constitute criteria for au-
thorship. Less charitably, these names may have been
included for fear by the authors of retribution if they
were left out, to please those in power, or in the belief
that the addition of prestigious names may aid in the
acceptance of the manuscript for publication. All of
these are clearly unethical actions.
Another form of gift authorship occurs between col-
leagues and collaborators. In this case a name of a
colleague is unjustifiably added to the manuscript in
the expectation that the favor will be returned. In this
way both authors unethically increase the number of
their publications.
In contrast, ghost authorship usually involves peo-
ple hierarchically junior to the author(s) such as post-
graduate students, postdoctoral fellows and visiting
researchers (often from another country). Here the
author hopes to gain greater credit for his own work
by not recognizing the contribution of others, who
may either have left his team by the time the work is
published or be too junior to protest. The authors
normally belittle the contributions of others by clas-
sifying these as merely the collection of data, the
supply of biological specimens, the provision of rea-
gents or not worth acknowledging, when in fact the
ghost author may have made a significant contribu-
tion to the study.
Another area of confusion surrounds people involved
in the preparation of manuscripts. Scientific illustra-
tors, medical writers or technical editors may have
made a substantial contribution to the clarity, read-
ability and presentation of the manuscript. Such con-
tributions should be fully acknowledged, but are in-
sufficient grounds on which to grant authorship.
Given the potential pitfalls in attributing authorship
and the few resources available to most editors what
can one do besides meekly accepting the list of au-
thors supplied with the manuscript? Although edi-
tors seldom know all the facts, there are a number of
measures we can take. We can require that the exact
contribution of each author and their address is clearly
stated with every manuscript submitted. Editors can
then examine these contributions against the ICMJE
criteria and question the inclusion of any author who
does not appear to meet them. Editors can send the
letter acknowledging receipt (this is obviously much
easier via e-mail) of the manuscript to all authors
listed, thereby alerting any who have been included
without their knowledge. Some journals ask all au-
thors again for their exact contributions just before
accepting the manuscript, and check for consistency
in the declarations.
Other measures can be taken once a manuscript has
been accepted. Editors can post a list of titles and
authors of forthcoming accepted manuscripts on the
journal’s web-site or in the current issue. Ghost, or
inadvertent guest, authors can thereby alert an editor
of their concerns.
Editors can also work on educating authors in their
particular scientific discipline. At relevant scientific
meetings or in editorials, one can explain the criteria
for authorship and stress the importance of discuss-
ing authorship when research is being planned. Edi-
*International Committee of Medical Journal Editors. Uniform requirements for manuscripts submitted to biomedical journals: writing and
editing for biomedical publication. Available from http://www.icmje.org [2006 Jul 7]
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tors can remind their colleagues that a final decision
on authorship and the order in which authors’ names
appear should be made before the paper is written.
This stimulates all authors to participate in the writ-
ing and approval of the paper and avoids the inclu-
sion of guest authors once the paper is completed. An
editor can also publish the stated contributions of
each author to the work together with the final arti-
cle. Public scrutiny can be a powerful deterrent to
unethical behavior.
Overlapping publications
Overlapping publications are another topic which
frequently provide ethical issues for the editor to re-
solve. They can be classified into four categories:
duplicate submission, duplicate publication, compet-
ing submissions, sibling publications.
The simultaneous submission of manuscripts to more
than one journal is considered unethical as there is
both a potential for disagreement over the right to
publish among the journals and the possibility of
unnecessary duplication of peer review and editing.
Co-publication is permissible when it is the result of
the deliberate synchronization of content, (usually
editorial) by editors who are using their respective
journals to achieve the broadest possible dissemina-
tion of particular content. Most of the editorial guide-
lines, written by consensus of editorial groups, have
been announced in this way.
A duplicate publication is considered redundant when
it substantially overlaps with an already published
article. Redundant publications are considered un-
ethical for many reasons: they waste the time of peer-
reviewers and editors, consume journals’ resources
and fill pages, increase the work of indexing and ab-
stracting services, distort the academic rewards’ sys-
tem and inflate the scientific literature, all for no ben-
efit other than to the author. Duplicate publications
may also infringe on copyright, and contribute to
flawed meta-analysis.
The latter reason is probably the most serious prob-
lem. The double counting of data from redundant pub-
lications can distort the results of meta-analyses and
affect the evidence on which decisions are taken. The
problem is unfortunately widespread. Von Elm et al12
screened 141 systematic reviews for evidence of du-
plicate publication. Fifty-six systematic reviews (40%)
reported (either in the published article or by contact-
ing authors) finding duplicate publications. The re-
dundant articles represented 8% (103) of the total arti-
cles reviewed and 9% (12,500) of the total number of
patients examined. Many among the 103 articles were
duplicated several times. Similarly Mojon-Azzi et al8
reported that in a study of 70 ophthalmologic journals
between 1997-2000 at least 32 journals were victim to
duplicate publication involving a minimum of 210
authors. The COPE* estimates that 13% of published
papers are repetitive publications.
Secondary publication may be acceptable for certain
kinds of papers such as guidelines, articles in different
languages or in commemorative journal issues. How-
ever, certain requirements have to be met, including
approval from the editors of both journals, prominent
citation of the primary publication, obviously distinct
readerships, and accurate reflection of data and inter-
pretations of the primary version. The ICMJE recom-
mends that a footnote on title page of the secondary
version should state the primary reference such as “This
article is based on a study first reported in the J. …”
Sibling publications are related papers submitted to
different journals with no cross citation. They are of-
ten the result of a researcher dividing up the results of
a study into as many papers as possible with a view to
increasing publication counts - also called “salami”
publication. This practice is also unethical as it frag-
ments the scientific record and is unhelpful to readers.
Editors can largely prevent this problem by asking
authors to provide all related papers, including those
in press and under review, when submitting a manu-
script. Journals generally expect authors to furnish
copies of any papers that overlap by more than 10%
with the current submission. Editors can educate their
authors that good publication practice is to provide
full disclosure, full citation and full discussion of
their related work.11 It is also unacceptable to dupli-
cate someone else’s work, by plagiarism - passing off
as one’s own the ideas or writings of another. Plagarism
can take a number of forms from verbatim copying of
scientific texts to the copying and pasting of phrases
and sentences by lazy or language-challenged au-
thors. Of course there is no problem in using some-
one else’s idea or writing provided this is made clear
in the text and the source is cited. A number of on-
line services are available for preventing plagiarism.
Some of these are run as a commercial service but
there are other sources that an editor can use with
creativity to detect cheating. An example is the
eTBLAST service of the University of Texas South-
western Medical Center.** By pasting paragraphs
*Committee on Publication Ethics - COPE. Guidelines on good publication and the Code of Conduct. Available from http://
www.publicationethics.org.uk/guidelines [2006 Jul 7]
**http://invention.swmed.edu/etblast/index.shtml
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from a suspected text, possible cases of scientific dis-
honesty can be detected.
Editors can monitor their own journals for overlap-
ping publications by using the ‘related article’ fea-
ture of PubMed. If a duplicate publication is identi-
fied the editor of the other journal should be promptly
informed. The two papers should be independently
reviewed for redundancy. The corresponding author
should be invited to refute the accusation and de-
scribe the circumstances in which it arose. If redun-
dancy is confirmed the editors should publish a no-
tice of duplicate publication in their journals.
OTHER WAYS EDITORS CAN IMPROVE
PUBLICATION PRACTICES
Editors can be severely limited in ability, or inclina-
tion, to police publication practices. They are often
obliged to juggle conflicting priorities such as: their
publishers’ interests in lean processes, their authors’
desire for ever faster decisions and shorter times to
publication, achieving increased press coverage of
scientific results and the thankless and invisible task
of protecting the integrity of the scientific record.
The COPE* has provided a 10-item checklist for edi-
torial standards and policies. Most of the items are
concerned with declared mechanisms (for peer review,
appealing editorial decisions, dealing with complaints,
pursuing misconduct, separating editorial and com-
mercial decisions on supplements and advertising)
rather than the more difficult measure of how things
are actually done: managing conflicts of interest, sat-
isfying editors that ethics committee approval has been
adequate, mitigating expertise and competitiveness
in small fields where the anonymity of peer review is
illusory. This checklist is an easy way for journals to
see immediately how they and their competitors stand.
Editors can easily record how their journals rank on
ratios of advertisements to scientific material - and
help to define the limits of excessive advertising.
Friedman & Richter1 established that the middle
ground for this ratio is 0.4-0.5; one page of advertise-
ment for every two pages of editorial content. High-
circulation general medical journals tend to have
higher ratios of advertising to content, while low-
circulation specialty journals have lower ratios. This
explicit evidence of how much advertising revenue
is potentially influencing editorial decisions can be
defended by clear separation of editorial and com-
mercial decision-making, and transparent statements
of advertising policies.
Academic institutions need to measure the output of
their workers, and this can produce unethical practice
depending on the measure chosen. Quantitative meas-
ures inspire producers to cheat, while qualitative ones
provide ample opportunity for the reviewers to do so.
An equivalent situation exists with the impact factor,
this flawed and easily-manipulated measure of a jour-
nal’s influence. In its favour, it does provide a perverse
incentive to not publishing by decreasing their de-
nominator (the number of citable items), journals can
increase their perceived impact for the same numera-
tor (the number of citations). The temptation to ma-
nipulate journals’ impact factors can be appealing to
editors. Recently, COPE held a debate on the deprav-
ity or otherwise of deliberately altering the impact fac-
tor. One way that this is done is by editors requesting
that authors insert references to their own journal as a
prerequisite to publication. Those in favour of this prac-
tice claimed that the measure of impact is so flawed
that editors have a duty to subvert it.
The impact factor may turn out to be a problem that is
eventually solved by evolution of the technology
that originally created it. Inadvertent authorship is
now routinely exposed by electronic manuscript
tracking systems that send e-mails unbidden to all
authors listed. As online content becomes the default
way of accessing scientific publications, Google’s
automated ranking of web pages may rapidly surpass
Institute for Scientific Information - ISI’s impact fac-
tor, as its algorithms evolve to stay ahead of self-
citation and other deliberate manipulations.
Recommendation that editors follow-up on suspi-
cions of misconduct in papers that are rejected are
unlikely to be tenable. Journals with over 80% rou-
tine rejection rates are too occupied in trying to deal
with the papers that they are going to publish, let
alone policing the authors of those that they have
rejected. What editors really hate ishaving to retract
published work. It looks bad, makes the press suspi-
cious of everything else, and invariably throws the
peer review process, and the editors’ own critical
skills into serious disrepute.
CONCLUSIONS
If editors really want to influence the ethical stand-
ards of publication, then they need to get involved
upstream, while research is being planned. Editors
may usefully participate, with the necessary declara-
tions of conflicting interests, in funding bodies, and
ethical review committees. Although the UK Depart-
ment of Health has recently concluded that ethical
*Committee on Publication Ethics - COPE. Guidelines on good publication and the Code of Conduct. Available from http://
www.publicationethics.org.uk/guidelines [2006 Jul 7]
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committees have no role in commenting on the sci-
entific worth of a research protocol,* for developing
countries, who may lack specific scientific review
committees, such input is very valuable. Member-
ships of such committees also provide a chance for
editors to comment on the eventual suitability of the
results for publication - regardless of where the au-
thors may choose to submit their papers. Actively
seeking, reviewing and publishing research protocols,
alongside or prior to the papers reporting outcomes
is also an option used by some journals.
The incentives for people to cheat are too great to ig-
nore. Until people are penalized, rather than rewarded,
for publishing more than is humanly possible without
recourse to duplication, gift authorship, plagiarism and
salami slicing, the rewards for getting away with it,
compared to the likelihood of getting caught, make
trying a very attractive proposition. As most publica-
tion misconduct appears to be in the attempt to multi-
ply the number of publications (by duplication, pla-
giarism and gift authorship), and the fact that the jour-
nals are largely complicit in this, as mutual needs co-
incide, it is only by seriously altering the incentives
for publication that the situation will change. What is
needed is an impact factor for individuals – calculated
for each author as the number of citations divided by
the number of publications; not as a summation of the
journal’s impact factors in which their papers have been
published. Editors could provide some guidance to
the scientific community on how much output is a
reflection of reasonable effort, how much is ‘remark-
able productivity’ and a range of publications above
which authors’ work becomes frankly suspect.14
Editors have a continual task to develop and share
reasonable standards of practice, and are in a good
position to suggest alternatives to the unbounded quan-
tity of scientific publication. A good start is familiari-
zation with the existing consensus guidelines on pub-
lication ethics, in order to inform explicit statements
about how each journal functions. Reviewers, editors,
authors and readers all then have a better chance to
understand, and abide by, the rules of publishing.
*Department of Health. 268110/Report of the Ad Hoc Advisory Group on the Operation of NHS Research Ethics Committees; 2005.
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